Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The National Institute for Health and Clinical Excellence (NICE) has issued its final draft guidance on the use of Bydureon (exenatide) as a treatment option for some people with Type 2 diabetes.
Exenatide is already in use as a twice daily injection known as Byetta, but Bydureon only needs injecting once a week.
http://www.diabetes.org.uk/About_us...pproves-weekly-treatment-for-Type-2-diabetes/
Exenatide is already in use as a twice daily injection known as Byetta, but Bydureon only needs injecting once a week.
http://www.diabetes.org.uk/About_us...pproves-weekly-treatment-for-Type-2-diabetes/